BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sinclair M, Hoermann R, Peterson A, Testro A, Angus PW, Hey P, Chapman B, Gow PJ. Use of Dual X-ray Absorptiometry in men with advanced cirrhosis to predict sarcopenia-associated mortality risk. Liver Int 2019;39:1089-97. [PMID: 30746903 DOI: 10.1111/liv.14071] [Cited by in Crossref: 13] [Cited by in F6Publishing: 19] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Haj Ali S, Abu Sneineh A, Hasweh R. Nutritional assessment in patients with liver cirrhosis. World J Hepatol 2022; 14(9): 1694-1703 [DOI: 10.4254/wjh.v14.i9.1694] [Reference Citation Analysis]
2 Johnston HE, Takefala TG, Kelly JT, Keating SE, Coombes JS, Macdonald GA, Hickman IJ, Mayr HL. The Effect of Diet and Exercise Interventions on Body Composition in Liver Cirrhosis: A Systematic Review. Nutrients 2022;14:3365. [DOI: 10.3390/nu14163365] [Reference Citation Analysis]
3 Hey P, Hoermann R, Gow P, Hanrahan TP, Testro AG, Apostolov R, Sinclair M. Reduced upper limb lean mass on dual energy X-ray absorptiometry predicts adverse outcomes in male liver transplant recipients. World J Transplant 2022; 12(6): 120-130 [DOI: 10.5500/wjt.v12.i6.120] [Reference Citation Analysis]
4 Santos BC, Fonseca ALF, Ferreira LG, Ribeiro HS, Correia MITD, Lima AS, Penna FGCE, Anastácio LR. Different combinations of the GLIM criteria for patients awaiting a liver transplant: Poor performance for malnutrition diagnosis but a potentially useful prognostic tool. Clin Nutr 2021;41:97-104. [PMID: 34864459 DOI: 10.1016/j.clnu.2021.11.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 Tantai X, Liu Y, Yeo YH, Praktiknjo M, Mauro E, Hamaguchi Y, Engelmann C, Zhang P, Jeong JY, van Vugt JLA, Xiao H, Deng H, Gao X, Ye Q, Zhang J, Yang L, Cai Y, Liu Y, Liu N, Li Z, Han T, Kaido T, Sohn JH, Strassburg C, Berg T, Trebicka J, Hsu YC, IJzermans JNM, Wang J, Su GL, Ji F, Nguyen MH. Effect of sarcopenia on survival in patients with cirrhosis: A systematic review and meta-analysis. J Hepatol 2021:S0168-8278(21)02174-7. [PMID: 34785325 DOI: 10.1016/j.jhep.2021.11.006] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 16.0] [Reference Citation Analysis]
6 Lai JC, Tandon P, Bernal W, Tapper EB, Ekong U, Dasarathy S, Carey EJ. Malnutrition, Frailty, and Sarcopenia in Patients With Cirrhosis: 2021 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2021;74:1611-44. [PMID: 34233031 DOI: 10.1002/hep.32049] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 39.0] [Reference Citation Analysis]
7 Ayorinde T, Panayotova G, Sharma A, Lunsford KE. Clinical and biomarker assessment of frailty in liver transplantation. Curr Opin Organ Transplant 2021. [PMID: 34343156 DOI: 10.1097/MOT.0000000000000911] [Reference Citation Analysis]
8 Tandon P, Montano-Loza AJ, Lai JC, Dasarathy S, Merli M. Sarcopenia and frailty in decompensated cirrhosis. J Hepatol 2021;75 Suppl 1:S147-62. [PMID: 34039486 DOI: 10.1016/j.jhep.2021.01.025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 21] [Article Influence: 3.0] [Reference Citation Analysis]
9 Cañamares-Orbis P, Bernal-Monterde V, Sierra-Gabarda O, Casas-Deza D, Garcia-Rayado G, Cortes L, Lué A. Impact of Liver and Pancreas Diseases on Nutritional Status. Nutrients 2021;13:1650. [PMID: 34068295 DOI: 10.3390/nu13051650] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
10 Son SW, Song DS, Chang UI, Yang JM. Definition of Sarcopenia in Chronic Liver Disease. Life (Basel) 2021;11:349. [PMID: 33923561 DOI: 10.3390/life11040349] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
11 Eriksen CS, Kimer N, Suetta C, Møller S. Arm lean mass determined by dual-energy X-ray absorptiometry is superior to characterize skeletal muscle and predict sarcopenia-related mortality in cirrhosis. Am J Physiol Gastrointest Liver Physiol 2021;320:G729-40. [PMID: 33729006 DOI: 10.1152/ajpgi.00478.2020] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
12 Williams FR, Milliken D, Lai JC, Armstrong MJ. Assessment of the Frail Patient With End-Stage Liver Disease: A Practical Overview of Sarcopenia, Physical Function, and Disability. Hepatol Commun 2021;5:923-37. [PMID: 34141980 DOI: 10.1002/hep4.1688] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
13 Abdelbasset WK, Nambi G, Elsayed SH, Moawd SA, Ibrahim AA, Verma A, Tantawy SA, Kamel DM, Saleh AK, Aldhafian OR, Nwihadh NB. Prevalence and Nonpharmacological Interventions for Sarcopenia among Cirrhotic Patients. Dis Markers 2021;2021:8866093. [PMID: 33628339 DOI: 10.1155/2021/8866093] [Reference Citation Analysis]
14 Lee CM, Kang BK, Kim M. Radiologic Definition of Sarcopenia in Chronic Liver Disease. Life (Basel) 2021;11:86. [PMID: 33504046 DOI: 10.3390/life11020086] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Lee CM, Kang BK, Kim M. Radiologic Definition of Sarcopenia in Chronic Liver Disease.Life (Basel). 2021;11. [PMID: 33504046 DOI: 10.3390/life11020086.] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Santos LAA, Lima TB, Qi X, Paiva SAR, Romeiro FG. Refining dual-energy x-ray absorptiometry data to predict mortality among cirrhotic outpatients: A retrospective study. Nutrition 2021;85:111132. [PMID: 33545545 DOI: 10.1016/j.nut.2020.111132] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Ohara M, Suda G, Kimura M, Maehara O, Shimazaki T, Shigesawa T, Suzuki K, Nakamura A, Kawagishi N, Nakai M, Sho T, Natsuizaka M, Morikawa K, Ogawa K, Sakamoto N. Computed tomography, not bioelectrical impedance analysis, is the proper method for evaluating changes in skeletal muscle mass in liver disease. JCSM Rapid Communications 2020;3:103-14. [DOI: 10.1002/rco2.20] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
18 Stirnimann J, Stirnimann G. Nutritional Challenges in Patients with Advanced Liver Cirrhosis. J Clin Med 2019;8:E1926. [PMID: 31717529 DOI: 10.3390/jcm8111926] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
19 Sinclair M. Controversies in Diagnosing Sarcopenia in Cirrhosis-Moving from Research to Clinical Practice. Nutrients. 2019;11:2454. [PMID: 31615103 DOI: 10.3390/nu11102454] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]